AstraZeneca’s Preventative COVID-19 Antibody Cocktail 83% Effective Over Six Months, Trials Show

November 19, 2021

Reuters (11/18, Aripaka, Burger) reports AstraZeneca on Thursday announced its COVID-19 “antibody drug cocktail offered 83% protection over six months.” The therapy, AZD7442 (Evusheld), “had previously been shown to confer 77% protection against symptomat...